December 23, 2002


WORCESTER, Mass. — Anthony Carruthers, PhD, has been appointed dean of the Graduate School of Biomedical Sciences (GSBS) at the University of Massachusetts Medical School (UMMS), announced Chancellor and Dean Aaron Lazare. Dr. Carruthers, a member of the GSBS faculty since 1983, replaces Thomas B. Miller, Jr., PhD, who retired in June.


“Dr. Carruthers has said that his research is a ‘life-motivating interest,’ a description that captures the passion for his work that will be, I am sure, a hallmark of his tenure as GSBS dean,” said Dr. Lazare. “I fully expect that he will serve as an excellent advocate for students and for the highest standards of accomplishment in education and research, and know that he shares our common goal of elevating GSBS programs to national distinction.”  


“The search committee was unanimous in its decision to propose Dr. Carruthers as the outstanding candidate for dean of the GSBS,” said Leslie Berg, PhD, professor of pathology and chair of the search committee. “Superior academically, Dr. Carruthers is a fair, articulate and well-respected colleague and teacher. In addition, his long academic career at UMMS has given him a deep understanding of the institution; he is sincerely committed to the school and the graduate program. Finally, he is an exceptional researcher who will be an inspiration to the faculty as well as the students.”


A professor of biochemistry & molecular pharmacology at UMMS, Carruthers also served as interim chair of the Department of Biochemistry & Molecular Pharmacology from 1997-2001. He graduated from the University of Manchester, United Kingdom, with a bachelor’s degree in physiology, and received his doctoral degree in cellular physiology from the University of London, King's College.  He served as visiting scientist with the Marine Biological Association of the United Kingdom and as a research associate in the Department of Physiology at King's College before joining UMMS.


Specializing in glucose transport across membranes, Carruthers is currently funded for more than $1.2 million by the National Institutes of Health for his research projects. He is author of numerous scholarly journal articles. He is also a reviewer for the National Science Foundation as well as for scientific publications including Biochemistry, Endocrinology, Journal of Membrane Biology, Journal of Physiology (UK) and Journal of Cellular Physiology.


The Graduate School of Biomedical Sciences is a faculty-initiated PhD program that trains scientists in a specialty area with a broad background in the basic medical sciences, in preparation to conduct research with direct relevance to human disease.  Graduates are trained to collaborate with scientists and physicians involved in clinical investigations and to initiate careers as educators in schools of the health professions or in the biotechnology industry through an interdisciplinary core curriculum, laboratory rotations and advanced elective coursework.


The University of Massachusetts Medical School, one of the fastest growing academic health centers in the country, has built a reputation as a world-class research institution, consistently producing noteworthy advances in clinical and basic research.  The Medical School attracts more than $134 million in research funding annually, 80 percent of which comes from federal funding sources.  Research funding enables UMMS scientists to explore human disease from the molecular level to large-scale clinical trials.  Basic and clinical research leads to new approaches for diagnosis, treatment and prevention of disease.



Alison Duffy, 508-856-2000